K160130 - BloodSTOP iX Battle Matrix (FDA 510(k) Clearance)

K160130 is an FDA 510(k) clearance for the BloodSTOP iX Battle Matrix. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).

Submitted by Lifescience Plus, Inc. (Mountain View, US). The FDA issued a Cleared decision on June 29, 2016 after a review of 161 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifescience Plus, Inc. devices